(Q40547323)

21 September 2017

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 (English)

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403188

26 March 2024

1 reference

acute myeloid leukemia

1 reference

childhood acute myeloid leukemia

inferred from title

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403188

26 March 2024

4

D. Reinhardt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586478

26 March 2024

author name string

T. Lehrnbecher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586478

26 March 2024

D. Varwig

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586478

26 March 2024

J. Kaiser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586478

26 March 2024

T. Klingebiel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586478

26 March 2024

U. Creutzig

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586478

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14586478

26 March 2024

publication date

1 January 2004

1 reference

full work available at URL

21 September 2017

https://www.nature.com/articles/2403188.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586478

https://www.nature.com/articles/2403188.pdf

26 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403188

https://www.nature.com/articles/2403188

26 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.LEU.2403188

26 March 2024

1 reference

21 September 2017

18

1 reference

21 September 2017

1

1 reference

21 September 2017

72-77

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403188

21 September 2017

0 references

cites work

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Bacterial infection and acute myeloblastic leukaemia: An analysis of two hundred patients undergoing intensive remission induction therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Therapy-induced alterations in host defense in children receiving therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Infections caused by viridans streptococci in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Infection caused by viridans streptococci in children with malignant hematologic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Viridans-group streptococcal infections in immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

Infections in children with acute myelogenous leukemia. Concepts of management and prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

7 January 2021

Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

7 January 2021

The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

7 January 2021

Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

7 January 2021

Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403188

7 January 2021

Identifiers

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference